CALIFORNIA STEM CELL INC

IRVINE, CA · CIK 0001375617 · Biotech · Acquired

Stem cell research and development services

california.space →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.9M
1 Form D · Feb 2012
176 months since last filing
Contracts
—
No federal contracts on record
Patents
19
1 granted · 18 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,950,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1468Nob Hill Therapeutics, Inc.—$2.2M
1469Aptevo Therapeutics Inc.—$5.6M
1470Up Therapeutics LLC——
1471CALIFORNIA STEM CELL INC—$1.9M
1472Aptorum Group Ltd—$1.6M
1473RESBIOTIC, INC.—$1.6M
1474UBIVAC, INC.—$1.5M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Christopher AirriessDirector · Executive Officer
  • David FroshDirector
  • Hans KeirsteadDirector · Executive Officer
  • Jason LivingstonExecutive Officer
  • Mark SurfasDirector

Patents

USPTO · 1 granted of 19
  • Antigen Presenting Cancer Vaccinegranted
  • Pluripotent Germ Layer Origin Antigen Presenting Cancer Vaccineapplication
  • High Purity Ovarian Cancer Stem Cells For Active Autologous Immune Therapyapplication
  • Bioreactor Cartridge And Systemapplication
  • Individualized High-purity Colon Carcinoma Stem Cells, Methods And Use Of The Sameapplication
  • Individualized High-purity Glioblastoma Multiforme Stem Cells, And Methods For Stimulating Immune Responseapplication
  • Individualized High-purity Ovarian Cancer Stem Cellsapplication
  • Cell Populations For Vascular Mimicry, Preparation And Methods Of Useapplication
  • Individualized High Purity Hepatocellular Carcinoma Stem Cells, Methods And Use Of The Sameapplication
  • Gamma Interferon Treated Pluripotent Germ Layer Origin Antigen Presenting Cancer Vaccineapplication
  • Pluripotent Germ Layer Origin Antigen Presenting Cancer Vaccineapplication
  • Antigen Presenting Cancer Vaccine With Gamma Interferonapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.